ZANTE GREG 内部人交易：近期 SEC Form 4 交易
过去 18 个月，ZANTE GREG（CIK 1264949）在 1 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-07-29）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-29 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 买入 | 31,667 | $0 |
| 2026-07-29 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 卖出 | 21,217 | $710,141 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 买入 | 41,000 | $0 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 买入 | 32,049 | $0 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 卖出 | 31,961 | $1.0M |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 卖出 | 13,900 | $463,982 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 卖出 | 10,300 | $352,672 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 卖出 | 1,500 | $48,135 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 买入 | 11,117 | $0 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 卖出 | 6,185 | $216,475 |
| 2025-07-03 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 买入 | 7,667 | $0 |
| 2025-07-03 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | 卖出 | 4,266 | $118,424 |
来源：SEC Form 4 申报文件 · 截至 2026-07-29